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Neurovascular Aspects of Skin Neurogenic
Inflammation
Aisah A. Aubdool1 and Susan D. Brain1
Neurogenic inflammation is involved in skin inflam-
mation. It is hypothesized that it is involved in the
pathogenesis of the common chronic cutaneous
vascular disorder rosacea, but the exact mechanism
of action is currently unknown. Transient receptor
potential vanilloid 1 (TRPV1) and ankyrin 1 (TRPA1) are
widely expressed on primary sensory neuron endings
and non-neuronal cells such as keratinocytes. Here
we describe the potential for TRPV1 and TRPA1
receptors to be involved in the pathophysiology of
rosacea due to their polymodal activation, including
cold and hot temperature, pungent products from
vegetable and spices, reactive oxygen species, and
mechanical stimuli. We discuss the role of both
receptors and the sensory neuropeptides that they
release in inflammation and pain sensation and
evidence suggesting that both TRPV1 and TRPA1
receptors may be promising therapeutic targets for
the treatment of the inflammatory symptoms of
rosacea.
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BACKGROUND TO ROSACEA AND TREATMENT
Rosacea, a common and chronic cutaneous vascular
disorder, currently affects approximately 45 million people
worldwide, over the age of 30 years (Abram et al., 2010).
Although women are commonly more affected than men in
the early stages of this disorder (Berg and Liden, 1989), once
affected, men can progress to the advanced stages more often
than women (Buechner, 2005). The National Rosacea Society
committee has developed a classification system that is based
on four stages of the lesion morphology of rosacea: erythe-
matotelangiectatic, papulopustular, phymatous, or ocular
(Wilkin et al., 2002). Although the underlying cause of this
disorder is currently unknown, genetic and environmental
factors are thought to contribute to the pathogenesis of
rosacea (Bamford, 2001). Rosacea primarily affects the face
and is characterized by persistent redness, inflammation, and
lesions of the skin, which may occur because of dysfunc-
tional regulation in the neurovascular system. This skin
disorder has multiple associated signs and symptoms, such as
increased frequency of skin flushing, itching, persistent
intensification of erythema, facial edema, swelling papules,
pustules, and fibrosis. The pathophysiology of rosacea is
multifactorial, and triggering factors include stress, meno-
pause, and alcohol consumption, environmental expo-
sures such as temperature extremes and sun exposure, certain
foods such as spices, wind, and temperature extremes
(Crawford et al., 2004).
It is well established that rosacea is a recurrent disease that
may require long-term therapy such as topical and oral
antibiotics, but this may lead to the development of
antibiotic-resistant organisms (Berman et al., 2007). Inflam-
mation has a central role in the pathogenesis of rosacea and
is usually treated with noninflammatory agents; flushing
episodes are with vasoconstrictor agents and telangiectasias
with laser and light therapy (Baldwin, 2007). There is
currently no cure for rosacea, but the combinations of
medical and psychological approaches can improve the
symptoms of this skin disorder. As there is no laboratory
benchmark test, and the basic pathophysiology and etio-
pathogenesis remain unclear (Crawford et al., 2004), the
diagnosis of rosacea relies on the basis of recognizing
morphological characteristics of the disorder. This includes
clinical manifestations, histology, and multiple factors
initiating or worsening the skin disorder.
Primary sensory neurons are known to innervate the skin,
and their stimulation in response to temperature changes,
mechanical or chemical stimuli leads to release of vasoactive
inflammatory neuropeptides. The role of these neuropeptides
in inducing inflammation qualifies them for a role in the
pathogenesis of rosacea. For example, flushing has been
suggested to be controlled by two vasodilatory mechanisms
including humoral substances and neuronal stimuli (Wilkin,
1988), but the exact mechanism of action is unknown. The
recent discovery of the novel class of nonselective cation
channels, the transient receptor potential (TRP) channels, has
increased our understanding of how sensory nerve endings
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are activated to release vasoactive neuropeptides, and hence
may enhance our knowledge on the pathophysiology of the
inflammatory process in different stages of rosacea. This
review discusses the pathogenesis of rosacea from current
clinical observations and laboratory research, as well as the
proposed role of TRP channels such as TRPV1 and TRPA1 in
this common skin disorder.
TRP CHANNELS AND OBSERVATIONAL LINKS TO THE
PATHOPHYSIOLOGY OF ROSACEA
The TRP channel receptor family is currently composed of 28
channels with seven subfamilies based on the sequence
homology (Nilius et al., 2007). The TRP channels are
ubiquitously expressed throughout the body on neuronal
and non-neuronal tissues, and are predicted to have six
transmembrane proteins, with a pore loop domain between
the fifth and sixth transmembrane (Nilius et al., 2007). It is
well established that TRP channels are polymodal and
functionally diverse. Recent studies have focused on vanilloid
1 (TRPV1), also known as the ‘‘capsaicin receptor’’ or the
VR1, and ankyrin 1 (TRPA1) channels. Both channels have
multiple functions as sensors in cells, and have a prominent
role in pain sensation and inflammation (Nilius et al., 2007).
They respond to a great number of stimuli such as natural
chemical compounds, cold or hot temperature extremes,
mechanical stimuli (Figure 1), and changes in lipid bilayer
(Nilius et al., 2007). There are contrasting results in the
literature on whether mammalian TRPA1 is mechanosensi-
tive, and this remains an important hypothesis for future
research in this field.
TRP CHANNELS AS THERMOSENSORS IN ROSACEA?
Both TRPA1 and TRPV1 channels display distinct thermal
activation threshold; interestingly, a survey conducted by the
National Rosacea Society in 2002 showed that hot and cold
weather is a common aggravating factor for 53% and 36% of
rosacea patients, respectively, (Blount and Pelletier, 2002). It
is well known that temperature changes can be linked to pain
and burning sensation, as experienced in rosacea patients.
Indeed, earlier studies by Brain et al. (1990) have shown that
brief exposure of the forearm to cold temperature (B5 1C)
triggers a localized reactive hyperemia in humans, which
may involve microvascular mechanisms. Noxious cold
temperatures (B17 1C) can directly activate TRPA1 channels
in heterologous expression systems (Story et al., 2003).
However, there is significant debate regarding the role of
TRPA1 as a ‘‘cold sensor’’ channel, as studies from other
groups failed to reproduce cold responsiveness in TRPA1
(Jordt et al., 2004; Nagata et al., 2005). Although there is
increasing evidence from cellular and behavioral studies in
TRPA1-deficient mice that TRPA1 is not required for acute
cold-induced pain in vivo (Bautista et al., 2006), other groups
are showing that pharmacological blockade of TRPA1
channels in primary sensory neurons can reverse cold-
induced hyperalgesia caused by inflammation and nerve
injury (Obata et al., 2005). Karashima et al. (2009) also
recently showed that TRPA1 functions as a sensor for noxious
cold both in vivo and in vitro. Using whole-cell patch
recordings, they showed that TRPA1-expressing Chinese
Hamster ovary cells were activated by cold temperature
(10 1C). Furthermore, they demonstrated that cold-induced
nociceptive behavior was dependent on TRPA1 in mice
in vivo (Karashima et al., 2009).
Interestingly, another TRP channel (melastin) TRPM8 is
also activated at temperatures belowB23 1C (Colburn et al.,
2007). Using TRPM8/TRPA1 double-knockout mice, Knowl-
ton et al. (2010) recently showed that noxious cold signaling
is exclusive to TRPM8 only, mediating neural and behavioral
responses to cold and cold mimetics. Nevertheless, the
results from Del Camino et al. (2010) also support the
findings that TRPA1 is likely to have a comparatively minor
role in acute cold sensation. They showed that once TRPA1
receptors are activated by an agonist in vitro and in vivo, they
have a significant role in producing cold allodynia; hence,
TRPA1 is now considered a key mediator of cold hypersensi-
tivity in disease states where endogenous proinflammatory
mediators of the channel are present. It remains to be
determined whether cold-induced inflammatory responses in
rosacea are directly linked to TRPA1 or TRPM8 channels.
Both channels may have therapeutic potential.
Sun exposure and hot baths, or exercises are two common
precipitating factors that develop or aggravate the symptoms
of rosacea as they dilate cutaneous vessels because of
increase in core temperature (Bae et al., 2009). Facial skin
temperature has also been reported to be higher in rosacea
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Figure 1. The structure and activators of transient receptor potential
vanilloid 1 (TRPV1) and ankyrin 1 (TRPA1) receptors in primary sensory
neuron with a link to rosacea. Both receptors have similar structure, with
each subunit composed of six putative transmembrane domains with a pore
loop domain between the fifth and sixth transmembrane. TRPA1 and TRPV1
have distinct thermal activation and can be stimulated by pungent products
from vegetables and spices. Reactive oxygen species (ROS) can activate
TRPA1 and induce vasodilatation. Mediators, such as proteases, released in
inflammation function on protease-activated receptor 2 (PAR2) and enhance
activation of both receptors. TRPV1 and TRPA1 are colocalized in primary
sensory neuron and there is suggestion of a potential interaction between
them that regulates their activity.
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patients, and this increases the growth of bacteria (Dahl et al.,
2004). Although the skin microcirculation is used to regulate
body temperature, the exact mechanism of action is not clear.
Interestingly, using patch–clamp methods, Caterina et al.
(1997) showed that upon exposure to a rapid increase in
temperature (22–48 1C in 25 seconds), transfected human
embryonic kidney cells expressing TRPV1 produced similar
large inward currents evoked by the application of a TRPV1
agonist. These findings confirm TRPV1 as a thermal
transducer and that TRPV1-lacking mice are deficient in
responses to noxious heat and acute thermal stimuli (Caterina
et al., 2000). These results highlight that TRPV1 channels
have an essential role in thermal hypersensitivity in the
setting in inflammation.
Using quantitative thermal (32–50 1C) sensory testing,
Guzman-Sanchez et al. (2007) showed that the skin area
affected by rosacea has a significantly lower heat pain
threshold as compared with non-affected area in rosacea
patients or control subjects. The pathophysiology of this
cutaneous hypersensitivity is not fully understood but is
suggested to involve a neurogenic etiology and may involve
TRPV1 activation. Sensitive skin is known to be characterized
by various symptoms including prickling, burning, flushing,
and pain. Numerous studies in the past decade have focused
on developing novel selective and chemically diverse TRPV1
antagonists, as well as investigating their effects in preclinical
models of pain and inflammation. Acute pharmacological
antagonism of TRPV1 channels can lead to pronounced
hyperthermia in mouse and humans, but not in TRPV1
knockout mice (Gavva et al., 2007, 2008). However,
repeated dosing of TRPV1 antagonists to rats, dogs, and
monkeys attenuated this hyperthermia response (Gavva et al.,
2007); this finding suggests that TRPV1 can have a pivotal
role in core body temperature homeostasis at the receptor
level (Gunthorpe and Chizh, 2009). The mechanisms are
unknown; however, it has been suggested that TRPV1 may
regulate temperature via peripheral mechanisms in the
abdominal cavity (Steiner et al., 2007).
From the above information, one may hypothesize that hot
and cold temperatures may directly activate TRPV1 and
TRPA1, respectively, and mediate the release of neuropep-
tides that enhance inflammation in rosacea. Moreover, we
hypothesize that if these channels are involved in the onset of
rosacea, selective antagonists may function as beneficial
therapeutic agents.
SPICES INFLUENCE ROSACEA VIA ACTIVATION OF TRP
CHANNELS?
Rosacea patients often experience increased skin sensitivity
and frequent episodes of burning sensation after the
consumption of spices (Crawford et al., 2004). Interestingly,
exogenous agonists for both TRPA1 and TRPV1 channels are
compounds derived from natural products such as vegetables
and spices (Figure 1). The activation of TRPV1 by capsaicin,
the pungent chemical from chilli peppers, and TRPA1 by
cinnamaldehyde, the main constituent of cinnamon, lead to
intense and acute painful burning sensation (Nilius et al.,
2007), which may be similar to that observed in rosacea.
Apart from quantitative sensory testing, blood flow is
another sensitive marker of C-fiber neurovascular dysfunc-
tion, and hence may account for the significant burning and
flushing in rosacea (Guzman-Sanchez et al., 2007). Interest-
ingly, prolonged flushing, which lasts longer than 10minutes
(Crawford et al., 2004) in response to spices, alcohol, food
intolerance (Wilkin, 1988), menopausal, blushing, or vaso-
dilator therapy (Wilkin, 1980), is known to be the earliest
apparent component of rosacea. Studies have shown that
rosacea patients have dilated microvasculature and there is
an increase in blood flow in skin lesions of individuals with
papulopustular rosacea as compared with control subjects
(Guzman-Sanchez et al., 2007).
There is also some evidence to suggest that TRPA1 is
expressed in the skin (Atoyan et al., 2009; Denda et al.,
2010). Atoyan et al. (2009) used real-time PCR and western
blot analysis to show TRPA1 mRNA and protein levels,
respectively, in primary cultures of human epidermal
keratinocytes (KCs). Furthermore, using immunofluorescence
analysis, they showed that TRPA1 was located in the basal
layer of the epidermis, in the dermis, and in the epithelium of
the hair follicle (Atoyan et al., 2009). Activation of TRPA1 by
icilin, a pungent chemical from garlic, in primary human
epidermal KCs caused an increase in the expression of
proinflammatory cytokine IL-1, which is a key contributor to
skin inflammation, and this finding suggests a possible
functional role for TRPA1 in the human KCs (Atoyan et al.,
2009). Immunoreactivity to TRPA1 antibody was also
observed throughout the mouse epidermis, and topical
application of TRPA1 agonist (mustard oil or cinnamalde-
hyde) or brief cold exposure (10–15 1C) accelerated the
epidermal permeability barrier recovery rate by a TRPA1-
dependent mechanism (Denda et al., 2010). Further studies
are needed for a better understanding of the function of
TRPA1 in epidermal KCs. Interestingly, our group has shown
that capsaicin, the classical exogenous TRPV1 agonist,
stimulates an increase in mouse skin blood flow, which is
dependent on the release of vasodilator neuropeptides such
as substance P (SP) and calcitonin gene-related peptide
(CGRP; Grant et al., 2002; Starr et al., 2008), and that the
exogenous TRPA1 agonist mustard oil has a similar effect
(Grant et al., 2005). Our most recent study showed that
another TRPA1 agonist, cinnamaldehyde, can also cause
neurogenic vasodilatation in mouse skin, which is TRPA1
dependent (Pozsgai et al., 2010). These findings highlight that
TRPA1 and TRPV1 may be activated by the triggers of
rosacea, such as cold or hot temperatures and spices, to
mediate flushing or burning sensation episodes of rosacea.
TRPA1 is co-expressed in approximately 50% of all
TRPV1-positive sensory neurons (Andersson et al., 2008),
and this suggests a potential interaction between the two
receptors (Figure 2), although the potential mechanisms are
under debate. Salas et al. (2009) showed that mustard oil-
gated currents showed faster kinetics activation in TRPA1-
expressing than in TRPA1/TRPV1-co-expressing Chinese
Hamster ovary cells in vitro. They suggested that there
might be a downregulation of TRPA1 expression in
TRPV1 knockout mice. Our recent study in vivo showed that
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TRPA1-mediated vasodilatation following topical application
of mustard oil was significantly potentiated in TRPV1
knockout mice or CD1 mice pretreated with selective
antagonist SB366791 (Aubdool et al., 2011). Hence, there
may be a potential link between receptors function and
TRPV1 may be involved in regulating TRPA1 receptor-
mediated responses. It remains unknown whether
TRPA1–TRPV1 co-expression is exclusive on sensory neurons
or whether it is also seen in non-neuronal tissues. Future
studies investigating TRPA1 and TRPV1 expression profile
and their interactions would provide details on the pharma-
cological properties and function of these receptors, and may
potentially help in understanding how they may be involved
in the pathogenesis of rosacea.
SUBSTANCE P AND CGRP IN ROSACEA
Our studies have revealed that both activation of TRPV1 by
capsaicin and TRPA1 by mustard oil mediates the release
of neuropeptides (Grant et al., 2002; Starr et al., 2008).
Chizh et al. (2007) demonstrated that topical application of
capsaicin cream evoked a robust flare in human skin, which
was ultimately blocked by administration of the TRPV1
antagonist SB705498. In addition, Sinclair et al. (2010)
recently demonstrated that the novel oral CGRP antagonist,
telcagepant, was able to inhibit capsaicin-induced dermal
blood flow on the human forearm. These results highlight that
the axon reflex flare following TRPV1 activation is due to the
release of CGRP. CGRP is one of the most potent
microvascular vasodilator found in human skin, and it
enhances local inflammation as a consequence of increased
blood flow and its ability to modulate cell activities
(Brain et al., 1985, 1986; Figure 2). Although both CGRP
and SP have properties closely related to the pathogenesis of
rosacea, the role of CGRP in rosacea remains unknown.
Flushing results from the transient filling of the dilated
microvasculature (Marks, 2007), and this may potentially also
involve neuropeptides such as SP, known to have neurome-
diated vasodilator properties, functioning via neurokinin-1
receptors (Powell et al., 1993). Earlier studies by Kurkcuoglu
and Alaybeyi (1991) showed that there is an increase in SP-
immunoreactive nerves around the papillary dermal blood
vessels in erythematous papules of rosacea patients and,
interestingly, the serum level of this neuropeptide was shown
to be elevated in rosacea patients as compared with control
subjects (Powell et al., 1993). There is evidence that nerve
fibers in healthy human skin express TRP channels such as
TRPV1 and TRPM8 that co-localize with SP and CGRP
(Axelsson et al., 2009). Thus, activation of the TRPV1
receptor may enhance SP and CGRP release. It would be
interesting to investigate whether the increase in serum level
of SP is due to the activation of TRPV1, and whether the level
of expression of TRPV1 channels is altered in rosacea.
Lonne-Rahm et al. (2004) showed that laser treatment
reduced facial sensitivity, sensory nerve marker, and SP-
positive nerve fibers in the papillary dermis of 31 rosacea
patients. There is evidence that SP can also induce skin
edema formation and, interestingly, genetic deletion or
pharmacological blockade of neurokinin-1-receptor reduces
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Figure 2. Potential mechanisms of transient receptor potential vanilloid 1 (TRPV1)- and ankyrin 1 (TRPA1)-mediated inflammatory responses in rosacea.
TRPA1 and TRPV1 receptors are expressed on neuronal and non-neuronal tissues. Their activation leads to opening of the nonselective cation channels,
increasing the intracellular calcium concentrations and mediating the release of neuropeptides such as substance P (SP) and calcitonin gene-related peptide
(CGRP). SP can mediate an increase in vasodilatation and vascular permeability, leading to edema formation, and can also stimulate mast cells to release
inflammatory mediators such as histamine. SP can also prime leukocytes to induce the release of proteases and reactive oxygen species (ROS). CGRP relaxes
arteries and also mediates an increase in cutaneous blood flow. These inflammatory processes potentially lead to pain and itch.
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polymorphonuclear leukocyte accumulation in inflamed skin
of mice (Cao et al., 1999; Costa et al., 2006). Inflammatory
edema is known to appear rapidly if facial cutaneous
lymphatic vessels are acutely damaged. Furthermore, there
is a proliferation of widely dilated irregular vessels in the
disorganized dermis of facial skin biopsies taken from
patients experiencing an inflammatory episode in rosacea
(Marks and Harcourt-Webster, 1969). Telangiectasia and
hyperplasia of sebaceous glands represent the later phase of
vascular rosacea (Bamford, 2001), and telangiectasia results
because of massive dilation of the most superficial capillaries.
Interestingly, experiments conducted by Foreman et al.
(1983) suggested that SP functions additionally to stimulate
mast cells to release histamine and 5-hydroxytryptamine
(Brain and Cox, 2006). These mediators bind to histamine H1
receptors and serotonin 5-hydroxytryptamine-1 receptors,
respectively, causing nerve-mediated vasodilatation and
protein exudation. Moreover, earlier studies showed that
CGRP could potentiate edema formation if SP is active, and
that this induces increased vascular permeability in a certain
vascular bed of rabbit dorsal skin (Brain and Williams, 1985).
Hence, CGRP may function synergistically with other
inflammatory mediators such as SP to cause local edema.
In addition, CGRP also inhibits the degradation of SP, and
hence it facilitates its activity (Brain and Cox, 2006). These
findings suggest that the blockade of neuropeptide-driven
inflammatory processes resulting from activation of TRPV1
and TRPA1 receptors may prove to be a novel therapeutic
approach to treating rosacea.
REACTIVE OXYGEN SPECIES IN ROSACEA
Substance P can prime polymorphonuclear neutrophils in
humans by functioning on neurokinin-1 receptors when
exposed to cytokines such as IL-8 (Dianzani et al., 2001), and
it can also induce the release of neutrophil-derived mediators
such as reactive oxygen species (ROS; Sterner-Kock et al.,
1999). There is evidence in the literature suggesting that
inflammation in the early stage of rosacea may be linked with
ROS such as superoxide anions, hydrogen peroxide, and
hydroxyl radicals, which are released by inflammatory cells
such as neutrophils (Miyachi, 2000). Bakar et al. (2007)
showed that the level of ROS was significantly higher in the
facial skin of patients with rosacea compared with healthy
control subjects or the same rosacea patients after being
treated with the antibiotic azithromycin. NADPH oxidase is
an enzyme involved in the production of ROS in neutrophils,
and is known to be involved in microbicidal activity
(Nabeebaccus et al., 2011). Previous studies have shown
that cathelicidin, a potent inflammatory peptide that is
upregulated in rosacea (Yamasaki et al., 2007), can stimulate
ROS generation by activation of NADPH oxidase and
intracellular Ca2þ mobilization (Zheng et al., 2007). It is
known that ROS are produced endogenously in inflammation
and hence may have a pivotal role in mediating inflammatory
hyperalgesia (Keeble et al., 2009). Interestingly, a link
between ROS and TRPV1 receptor activation has been
previously established in our group (Starr et al., 2008; Keeble
et al., 2009). TRPV1-mediated increase in cutaneous blood
flow was shown to be attenuated in the presence of the ROS-
degrading enzymes, superoxide dismutase, and the hydrogen
peroxidase scavenger, catalase, and most importantly with
treatment of selective NADPH inhibitor, apocynin, as well as
in mice in which gp91phox gene was deleted (Starr et al.,
2008). The proposed mechanism of action is that activation
of the TRPV1 receptor by capsaicin mediates the release of
vasodilatory neuropeptides such as SP and CGRP. This in turn
functions on vascular receptors to stimulate NADPH oxidase
and hence mediate ROS-dependent relaxation (Figure 2).
These results suggest that endogenous inflammatory media-
tors such as ROS released in rosacea may be involved in
mediating TRPV1-mediated neurogenic vasodilatation, and
there is also recent evidence that TRPA1 may function as an
oxidant sensor for vasodilator responses in vivo (Graepel
et al., 2011). The removal of ROS production by antagonism
of TRPV1 or TRPA1 receptors may be a novel therapeutic
target for anti-inflammatory drugs in rosacea.
PROTEASES IN ROSACEA
It is also known that protease activity is higher in the facial
skin of rosacea patients, and that antibiotics such as
tetracyclines can indirectly inhibit serine proteases (Acharya
et al., 2004). Yamasaki et al. (2007) demonstrated that there is
an increase in KC serine protease activity in facial skin where
symptoms of rosacea aggravate compared with non-affected
sites. Endogenous proteases released by neutrophils may also
degrade elastin and collagen, which further leads to a
compromised lymphatic system in the skin (Miyachi, 2000).
They also activate protease-activated receptors (PARs), which
are a group of seven transmembrane protein receptors. There
are currently four members of PAR (PAR1–4), and PAR2 has
been shown to be widely expressed in the human skin, and it
is activated by trypsin and chymotrypsin, which contribute to
inflammatory responses (Steinhoff et al., 2005). PAR2
activation has also been shown to induce neurogenic
inflammation by stimulating the release of SP and CGRP
from the spinal afferent neurons (Steinhoff et al., 2000). The
proinflammatory effects of PAR2 activation was also shown
to be mediated by nitric oxide, E-selectin, intercellular
adhesion molecule-1, and IL-6 (Seeliger et al., 2003) during
cutaneous inflammation in vivo (Seeliger et al., 2003).
Interestingly, several studies have suggested that PAR2
activation can enhance the activation of TRPV1 receptors
(see Grant et al., 2007), through a protein kinase C-
dependent pathway (Dai et al., 2004). Amadesi et al.
(2004) showed that PAR2 agonist can sensitize TRPV1-
mediated calcium mobilization in vitro, and that
PAR2-induced thermal hyperalgesia is abolished in TRPV1
knockout mice. There is also evidence that PAR2 and TRPA1
are colocalized in rat DRG neurons, and PAR2 activation can
increase TRPA1 currents upon activation on HEK293 cells
transfected with TRPA1 (Dai et al., 2007). Thus, it may be
possible that PAR2 is activated by proteases released in
inflammatory processes in rosacea, and this in turn leads to
sensitization of TRPV1 and TRPA1, which further results in
exacerbated TRPV1- and TRPA1-mediated inflammatory
responses.
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CONCLUSION
This review has discussed a range of mechanisms by which
TRPV1 and TRPA1 may contribute to the pathogenesis of
rosacea. Although our knowledge is incomplete, the central
role in cellular skin reactivity to various triggers of rosacea
might be attributed to both TRPA1 and TRPV1 receptors, as
they are located on neuronal and non-neuronal cells. The
activation of both receptors particularly in stimulating
sensory neuronal C-fibers to release vasoactive peptides such
as CGRP and SP may aggravate the symptoms of rosacea. The
role of TRPA1 and TRPV1 in inflammation and pain sensation
has been extensively studied. New evidence also suggests
that the co-expression of the receptors on the sensory neuron
may regulate the activity of each other as a result of
interactions between them at the receptor level. Under-
standing the role of TRPV1 and TRPA1 in experimental
models of rosacea and in human studies will enhance our
knowledge on the pathogenesis of rosacea. Evidence in the
literature so far strongly suggests that both TRPV1 and
TRPA1 may be involved in the inflammatory stages
of this skin disorder. The development of potent and highly
selective dual TRPV1/TRPA1 antagonist may reduce the
neurogenic-induced inflammatory symptoms of rosacea and
may be a beneficial therapeutic treatment for rosacea
patients.
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